Literature DB >> 12565010

Nuclear transport as a target for cell growth.

Tweeny R Kau1, Pamela A Silver.   

Abstract

The function of many key proteins and transcription factors involved in cell growth can be regulated by their cellular localization. Such proteins include the tumor suppressor p53 and the nuclear factor kappaB. Although the idea of trapping such proteins in either the nucleus or cytoplasm has been introduced as a potential therapeutic target, only two nuclear transport inhibitors have been reported. Here, we explore the roles of small-molecule inhibitors that cause target proteins to sequester in either the nucleus or cytoplasm. Methods of artificially targeting proteins to the nucleus or cytoplasm using peptide aptamer technology are also discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12565010     DOI: 10.1016/s1359-6446(02)02562-x

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  22 in total

1.  Identification of a small molecule inhibitor of importin β mediated nuclear import by confocal on-bead screening of tagged one-bead one-compound libraries.

Authors:  Martin Hintersteiner; Géza Ambrus; Janna Bednenko; Mario Schmied; Andrew J S Knox; Nicole-Claudia Meisner; Hubert Gstach; Jan-Marcus Seifert; Eric L Singer; Larry Gerace; Manfred Auer
Journal:  ACS Chem Biol       Date:  2010-10-15       Impact factor: 5.100

Review 2.  Inhibiting NF-κB activation by small molecules as a therapeutic strategy.

Authors:  Subash C Gupta; Chitra Sundaram; Simone Reuter; Bharat B Aggarwal
Journal:  Biochim Biophys Acta       Date:  2010-05-21

3.  Regulation and function of nuclear IκBα in inflammation and cancer.

Authors:  Ivana Vancurova; Ales Vancura
Journal:  Am J Clin Exp Immunol       Date:  2012-05-25

4.  Nuclear but not cytosolic phosphoinositide 3-kinase beta has an essential function in cell survival.

Authors:  Amit Kumar; Javier Redondo-Muñoz; Vicente Perez-García; Isabel Cortes; Monica Chagoyen; Ana C Carrera
Journal:  Mol Cell Biol       Date:  2011-03-07       Impact factor: 4.272

Review 5.  Nuclear export of proteins and drug resistance in cancer.

Authors:  Joel G Turner; Jana Dawson; Daniel M Sullivan
Journal:  Biochem Pharmacol       Date:  2011-12-20       Impact factor: 5.858

6.  The nucleoporin ELYS regulates nuclear size by controlling NPC number and nuclear import capacity.

Authors:  Predrag Jevtić; Andria C Schibler; Chase C Wesley; Gianluca Pegoraro; Tom Misteli; Daniel L Levy
Journal:  EMBO Rep       Date:  2019-05-13       Impact factor: 8.807

7.  The CRM1 nuclear export receptor controls pathological cardiac gene expression.

Authors:  Brooke C Harrison; Charles R Roberts; David B Hood; Meghan Sweeney; Jody M Gould; Erik W Bush; Timothy A McKinsey
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

8.  High-throughput sensing and noninvasive imaging of protein nuclear transport by using reconstitution of split Renilla luciferase.

Authors:  Sung Bae Kim; Takeaki Ozawa; Shigeaki Watanabe; Yoshio Umezawa
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-02       Impact factor: 11.205

Review 9.  Bifunctional recombinant proteins in cancer therapy: cell penetrating peptide aptamers as inhibitors of growth factor signaling.

Authors:  Claudia Buerger; Bernd Groner
Journal:  J Cancer Res Clin Oncol       Date:  2003-09-11       Impact factor: 4.553

10.  Identification of essential sequences for cellular localization in BRMS1 metastasis suppressor.

Authors:  José Rivera; Diego Megías; Carolina Navas; Jerónimo Bravo
Journal:  PLoS One       Date:  2009-07-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.